Addus HomeCare Corporatio... (ADUS)
NASDAQ: ADUS
· Real-Time Price · USD
114.29
1.49 (1.32%)
At close: Jun 16, 2025, 3:59 PM
116.65
2.06%
After-hours: Jun 16, 2025, 05:49 PM EDT
Addus HomeCare Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|
| Personal Care Revenue | 856.58M | 794.72M | 86.59M | 99.73M | 115.51M | 108.4M | 65.12M |
| Personal Care Revenue Growth | +7.78% | +817.77% | -13.18% | -13.66% | +6.56% | +66.47% | n/a |
| Home Health Revenue | 69.83M | 56.78M | 34.11M | 24.73M | 16.25M | 14.46M | 6.86M |
| Home Health Revenue Growth | +22.98% | +66.45% | +37.91% | +52.26% | +12.33% | +110.94% | n/a |
| Hospice Revenue | 228.19M | 207.16M | 70.5M | 61.41M | 42.65M | 38.79M | 18.85M |
| Hospice Revenue Growth | +10.15% | +193.82% | +14.80% | +44.00% | +9.95% | +105.78% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|
| New York Revenue | 40.7M | 39.2M | 42M |
| New York Revenue Growth | +3.83% | -6.67% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 73.22M | 71.36M | 62.8M | 63.58M | 61.06M | 60.77M | 60.27M | 57.4M | 56.36M | 54.47M | 54.23M | 55.09M | 53.15M | 49.54M | 46.28M | 48.17M | 45.43M | 44.21M | 40.81M | 42.1M | 42.29M | 38.14M | 35.95M | 30.22M | 29.26M | 28.94M | 28.22M | 26.41M | 21.46M | 19.66M | 19.36M | 19.01M | 20.91M | 19.26M | 23.21M | 19.56M | 22.19M | 17.97M | 18.04M | 17.42M | 17.15M |
| Selling, General, and Administrative Revenue Growth | +2.61% | +13.62% | -1.21% | +4.12% | +0.49% | +0.82% | +5.01% | +1.84% | +3.48% | +0.44% | -1.57% | +3.66% | +7.30% | +7.04% | -3.93% | +6.05% | +2.75% | +8.34% | -3.07% | -0.45% | +10.87% | +6.09% | +18.95% | +3.30% | +1.10% | +2.55% | +6.85% | +23.06% | +9.14% | +1.57% | +1.86% | -9.08% | +8.54% | -17.01% | +18.66% | -11.86% | +23.50% | -0.42% | +3.55% | +1.57% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |